CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-31 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −2,679 | $40.74 | $109K | 195,706 |
| 2020-03-28 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −1,037 | $37.76 | $39K | 54,890 |
| 2020-03-28 | CAREY STEPHEN P. Vice President and CFO | Shares withheld for taxes | −953 | $37.76 | $36K | 24,497 |
| 2020-03-28 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −4,204 | $37.76 | $159K | 198,385 |
| 2020-03-04 | HAUGHEY THOMAS Director | Purchase | +3,000 | $45.05 | $135K | 11,291 |
| 2020-03-03 | HAUGHEY THOMAS Director | Purchase | +2,000 | $45.18 | $90K | 8,291 |
| 2019-08-20 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −5,512 | $68.18 | $376K | 2,281,283 |
| 2019-08-20 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −5,512 | $68.18 | $376K | 2,219,259 |
| 2019-08-19 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −2,067 | $68.30 | $141K | 2,286,795 |
| 2019-08-19 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −2,067 | $68.30 | $141K | 2,224,771 |
| 2019-08-16 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −26,349 | $68.09 | $1.8M | 2,226,838 |
| 2019-08-15 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −9,315 | $69.34 | $646K | 2,253,187 |
| 2019-08-14 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −26,360 | $69.89 | $1.8M | 2,262,502 |
| 2019-08-13 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −20,821 | $71.77 | $1.5M | 2,288,862 |
| 2019-08-12 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −21,016 | $71.45 | $1.5M | 2,309,683 |
| 2019-08-09 | MERIDIAN VENTURE PARTNERS II LP 10% owner | Sale | −19,860 | $71.70 | $1.4M | 2,330,699 |
| 2019-05-24 | NASH DAVID Director | Purchase | +1,445 | $68.76 | $99K | 5,236 |
| 2019-05-17 | Marken James G. SVP Ops & Prod Dev | Sale | −8,907 | $70.67 | $629K | 61,230 |
| 2019-05-16 | Brown Robert E. JR Director | Exercise or conversion | +1,042 | $6.36 | $7K | 21,394 |
| 2019-05-16 | Brown Robert E. JR Director | Exercise or conversion | +1,167 | $33.00 | $39K | 22,561 |
Page 27 of 31 · 601 trades